NS3 epitope-decorated nanoparticles produced in bacteria trigger potent T cell immunity against hepatitis C virus
{{output}}
The highly conserved human leukocyte antigen-A2 (HLA-A2)-restricted epitope NS3-1073 represents a promising candidate for a therapeutic vaccine against hepatitis C virus (HCV). In this study, we engineered a set of fusion proteins based on the artificial pepti... ...
